MW, K., JH, P., M, L., SG, L., JS, O., S, P., . . . HM, C. (2026). Prime-edited isogenic hiPSC-derived cardiomyocyte model of short QT syndrome type 3 reveals electrophysiological phenotypes and differential drug responses. Life sciences, 402, 124573. https://doi.org/10.1016/j.lfs.2026.124573
Chicago Style (17th ed.) CitationMW, Kim, et al. "Prime-edited Isogenic HiPSC-derived Cardiomyocyte Model of Short QT Syndrome Type 3 Reveals Electrophysiological Phenotypes and Differential Drug Responses." Life Sciences 402 (2026): 124573. https://doi.org/10.1016/j.lfs.2026.124573.
MLA (9th ed.) CitationMW, Kim, et al. "Prime-edited Isogenic HiPSC-derived Cardiomyocyte Model of Short QT Syndrome Type 3 Reveals Electrophysiological Phenotypes and Differential Drug Responses." Life Sciences, vol. 402, 2026, p. 124573, https://doi.org/10.1016/j.lfs.2026.124573.